Case Study: Hospital Technology Commercialization
Background. A major New England Children’s Hospital had a substantial portfolio of pediatric devices and inventions, and an active IP licensing program. The Hospital’s IP leadership recognized that several devices and inventions could produce substantial independent companies, and initiated a first-ever program to commercialize them. We were hired to help identify the right devices; build an investor constituency for the program and devices; develop business overviews; build a network for prototype, business plan, and leadership development; and work closely with the IP staff.
Activities. We vetted approximately 20 device opportunities and selected 5-8 for initial review and inclusion in the program. We also organized Children's Angels, a membership organization of approximately 35 qualified angel and early stage venture investors. We organized two successful meetings of the group; and members of Children's Angels decided to license three of the identified technologies. We also completed organization of the prototype development, business plan, and leadership networks, and oversaw development of the first four Executive Summaries.
Status. After a change in licensing office management, we ceased our supporting activities. They were not able to maintain the Angel network on their own and none of the identified technologies were ever brought to market.
Activities. We vetted approximately 20 device opportunities and selected 5-8 for initial review and inclusion in the program. We also organized Children's Angels, a membership organization of approximately 35 qualified angel and early stage venture investors. We organized two successful meetings of the group; and members of Children's Angels decided to license three of the identified technologies. We also completed organization of the prototype development, business plan, and leadership networks, and oversaw development of the first four Executive Summaries.
Status. After a change in licensing office management, we ceased our supporting activities. They were not able to maintain the Angel network on their own and none of the identified technologies were ever brought to market.
